Compare PNFP & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNFP | MEDP |
|---|---|---|
| Founded | 2000 | 1992 |
| Country | United States | United States |
| Employees | 3595 | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 12.9B |
| IPO Year | N/A | 2016 |
| Metric | PNFP | MEDP |
|---|---|---|
| Price | $87.47 | $498.34 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 13 |
| Target Price | $110.87 | ★ $498.25 |
| AVG Volume (30 Days) | ★ 1.2M | 257.3K |
| Earning Date | 04-22-2026 | 04-22-2026 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 15.28 |
| Revenue | N/A | N/A |
| Revenue This Year | $163.66 | $13.15 |
| Revenue Next Year | $7.77 | $7.47 |
| P/E Ratio | ★ $12.24 | $32.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $81.08 | $250.05 |
| 52 Week High | $120.39 | $628.92 |
| Indicator | PNFP | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 61.95 |
| Support Level | $83.62 | $489.09 |
| Resistance Level | $89.29 | $501.30 |
| Average True Range (ATR) | 2.10 | 14.70 |
| MACD | 0.88 | 6.36 |
| Stochastic Oscillator | 86.76 | 94.51 |
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.